Literature DB >> 9701260

Anti-Gal(alpha)1-3Gal antibody response to porcine bone marrow in unmodified baboons and baboons conditioned for tolerance induction.

T Kozlowski1, R Monroy, Y Xu, R Glaser, M Awwad, D K Cooper, D H Sachs.   

Abstract

BACKGROUND: Mixed lymphohematopoietic chimerism can provide an effective means of inducing longterm immunological tolerance and has been documented in a monkey allograft model. A conditioning regimen including nonmyeloablative or myeloablative irradiation and splenectomy has been used to induce chimerism in a pig-to-primate transplantation model. Since the presence of anti-Gal(alpha)1-3Gal (alphaGal) natural antibodies leads to the hyperacute rejection of pig organs transplanted into primates, extracorporeal immunoaffinity adsorption (EIA) of anti-alphaGal antibodies is also included in the regimen. The effect of the tolerance induction protocol on the anti-alphaGal antibody response has been assessed.
METHODS: Anti-alphaGal antibody was measured after the EIA of plasma through an alphaGal immunoaffinity column in baseline studies involving two unmodified baboons, one splenectomized baboon, and one baboon that received a challenge with porcine bone marrow (BM), and in three groups of baboons (n=2 in each group) that received different conditioning regimens for tolerance induction. Group 1 received a nonmyeloablative conditioning regimen without porcine BM transplantation. Group 2 received nonmyeloablative conditioning with pig BM transplantation and pig cytokine therapy. Group 3 received myeloablative conditioning, an autologous BM transplant (with BM depleted of CD2+ or CD2+/CD20+ cells), and pig BM transplantation.
RESULTS: In the baseline studies, a single EIA of anti-alphaGal antibodies in an unmodified animal initially depleted anti-alphaGal antibody, followed by a mild rebound. Nonmyeloablative conditioning (group 1) in the absence of pig cell exposure reduced the rate of anti-alphaGal antibody return. Pig BM cells markedly stimulated anti-alphaGal antibody production in an unmodified baboon (alphaGal IgM and IgG levels increased 40- and 220-fold, respectively). This response was significantly reduced (to an only 2- to 5.5-fold increase of IgM and IgG) in baboons undergoing nonmyeloablative conditioning (group 2). A myeloablative conditioning regimen (group 3) prevented the antibody response to pig BM, with the reduction in response being greater in the baboon that received autologous BM depleted of both CD2+ and CD20+ cells. No new antibody directed against pig non-aGal antigens was detected in any baboon during the 1 month follow-up period.
CONCLUSIONS: (i) EIA of anti-alphaGal antibody in unmodified baboons results in a transient depletion followed by a mild rebound of antibody; (ii) exposure to pig BM cells results in a substantial increase in anti-alphaGal antibody production; (iii) a nonmyeloablative conditioning regimen reduces the rate of antibody return and (iv) markedly reduces the response to pig BM cells; (v) the anti-alphaGal response is completely suppressed by a myeloablative regimen if CD2+ and CD20+ cells are eliminated from the autologous BM inoculum. Furthermore, (vi) challenge with pig BM cells appears to stimulate only an anti-alphaGal antibody response without the development of other (non-alphaGal) anti-pig antibodies. We conclude that regimens used for T-cell tolerance induction can be beneficial in reducing the anti-alphaGal antibody response to porcine BM.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9701260     DOI: 10.1097/00007890-199807270-00006

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  8 in total

1.  Occurrence of specific humoral non-responsiveness to swine antigens following administration of GalT-KO bone marrow to baboons.

Authors:  Adam Griesemer; Fan Liang; Atsushi Hirakata; Erica Hirsh; Diana Lo; Masayoshi Okumi; Megan Sykes; Kazuhiko Yamada; Christene A Huang; David H Sachs
Journal:  Xenotransplantation       Date:  2010 Jul-Aug       Impact factor: 3.907

Review 2.  Current progress in xenogeneic tolerance.

Authors:  Kazuhiko Yamada; Joseph Scalea
Journal:  Curr Opin Organ Transplant       Date:  2012-04       Impact factor: 2.640

Review 3.  Achieving tolerance in pig-to-primate xenotransplantation: reality or fantasy.

Authors:  David H Sachs; Megan Sykes; Kazuhiko Yamada
Journal:  Transpl Immunol       Date:  2008-12-06       Impact factor: 1.708

4.  Renal and cardiac endothelial heterogeneity impact acute vascular rejection in pig-to-baboon xenotransplantation.

Authors:  C Knosalla; K Yazawa; A Behdad; N Bodyak; H Shang; L Bühler; S Houser; B Gollackner; A Griesemer; I Schmitt-Knosalla; H-J Schuurman; M Awwad; D H Sachs; D K C Cooper; K Yamada; A Usheva; S C Robson
Journal:  Am J Transplant       Date:  2009-05       Impact factor: 8.086

Review 5.  Modifying the sugar icing on the transplantation cake.

Authors:  David K C Cooper
Journal:  Glycobiology       Date:  2016-03-01       Impact factor: 4.313

6.  The innate immune response and activation of coagulation in alpha1,3-galactosyltransferase gene-knockout xenograft recipients.

Authors:  Mohamed Ezzelarab; Bertha Garcia; Agnes Azimzadeh; Hongtao Sun; Chih Che Lin; Hidetaka Hara; Sean Kelishadi; Tianshu Zhang; Yih Jyh Lin; Hao-Chi Tai; Robert Wagner; Jnanesh Thacker; Noriko Murase; Kenneth McCurry; Rolf N Barth; David Ayares; Richard N Pierson; David K C Cooper
Journal:  Transplantation       Date:  2009-03-27       Impact factor: 4.939

7.  Changes of the Structural and Biomechanical Properties of the Bovine Pericardium after the Removal of α-Gal Epitopes by Decellularization and α-Galactosidase Treatment.

Authors:  Jinhae Nam; Sun-Young Choi; Si-Chan Sung; Hong-Gook Lim; Seong-Sik Park; Soo-Hwan Kim; Yong Jin Kim
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2012-12-07

Review 8.  Recent strategies to overcome the hyperacute rejection in pig to human xenotransplantation.

Authors:  P Igaz
Journal:  Yale J Biol Med       Date:  2001 Sep-Oct
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.